Two AI startups secure mega-funding at high valuations
OpenEvidence, an AI platform for healthcare professionals, reached a $15 billion valuation after raising nearly $800 million in the past year. Investors include Nvidia, Thrive Capital, and Sequoia Capital. Separately, Island, an AI startup, raised $400 million in a Series F round led by Evolution Equity Partners, valuing it at $6.4 billion.
Sources: businessinsider.com · msn.com
“These valuations signal investor confidence in AI applications for niche verticals, despite broader market caution in late-stage funding.”
What it means
The funding rounds reflect a continued appetite for AI-driven solutions in specialized sectors like healthcare and enterprise tools. OpenEvidence’s $15 billion valuation is notably high for a company outside the consumer AI space, suggesting strong perceived demand for medical AI. Meanwhile, Island’s raise underscores sustained interest in enterprise AI, though its lower valuation relative to OpenEvidence may indicate sector-specific risk appetite. Both rounds highlight how AI startups with clear use cases are attracting capital even as early-stage funding slows.
Read the original reporting
The outlets below did the original reporting.
Related briefs
This brief was drafted automatically from the sources above and published under our editorial policy. Spotted an error? Tell us.